IT Pharma attends the IMCAS World Congress in Paris

IT Pharma attended the IMCAS World Congress in Paris to introduce Prostrolane Inner B of Caregen

The Navarran group made the most of the congress to sign the exclusive distribution agreement in Spain and Mexico for the Prostrolane line by Caregen.

On 1st February, IT Pharma attended the IMCAS WORLD CONGRESS on aesthetic medicine, which took place in Paris, where it collaborated by exhibiting and introducing Prostrolane Inner B., by Caregen Co., assisted by Dr Chung, CEO of the Korean firm.

Doctor Juan Miguel Pérez from the Pérez Díaz Clinic – a regular collaborator of the group – gave a speech about the product and revealed ten clinical cases in which the effectiveness and quality of Inner B. was left undisputable, accompanying other collaborating medical professionals from the Korean group.

Taking full advantage of the visit to the French capital, an importation and exclusive distribution agreement was signed with Caregen for the Prostrolane line. The agreement was signed by Dr Chung and the IT Pharma management, which has reached an agreement with TOV Medical, collaborators in distribution in Spain, who have been given the responsibility for marketing Inner B. within Spain.

The congress concluded with a gala dinner, attended by all the trusted distributers and doctors from the Korean firm.


Make a comment